Treatment of respiratory syncytial virus (RSV) infection with combined oral Ribavirin and IVIG following allogeneic HSCT is effective and safe

被引：0

作者：

Watson, Edmund ^{[1
]}

Lubowiecki, Marcin ^{[1
]}

Balassa, Katalin ^{[1
,2
]}

Cash, Rebecca ^{[1
]}

Maouche, Nadjoua ^{[1
]}

Barton, Daja ^{[1
]}

Ellis, Mandy ^{[1
]}

Rowley, Lara ^{[1
]}

Wareham, Denise ^{[1
]}

Costa, Claudia ^{[1
]}

Miller, Rachel ^{[1
]}

Jeffery, Katie ^{[3
]}

Misbah, Siraj ^{[4
]}

Pawson, Rachel ^{[1
,2
]}

Danby, Robert ^{[1
]}

Rocha, Vanderson ^{[1
,2
]}

Peniket, Andy ^{[1
]}

机构：

[1] Oxford Univ Hosp NHS Fdn Trust, Dept Haematol, Oxford, England

[2] NHS Blood & Transplant, Oxford, England

[3] Oxford Univ Hosp NHS Fdn Trust, Dept Microbiol, Oxford, England

[4] Oxford Univ Hosp NHS Fdn Trust, Dept Clin Immunol, Oxford, England

来源：

BONE MARROW TRANSPLANTATION | 2018年 / 53卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P602

引用

页码：594 / 595

页数：2

共 50 条

[1] ROLE OF ORAL RIBAVIRIN FOR TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN PATIENTS UNDERGOING IN ALLOGENEIC TRANSPLANTATION
Madrigal Toscano, M. D.
Raposo Puglia, J. A.
Saldana Moreno, R.
Verdugo Cabeza de Vaca, V.
Rubio Sanchez, V.
Garzon Lopez, S.
BONE MARROW TRANSPLANTATION, 2016, 51 : S396 - S397
[2] Oral Ribavirin Is a Cost-Effective Alternative to Intravenous Ribavirin for Respiratory Syncytial Virus (RSV) Infection after Lung Transplantation (LTx)
Burrows, F. S.
Carlos, L. M.
Marriott, D.
Havryk, A.
Plit, M.
Glanville, A. R.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S109 - S109
[3] Oral Ribavirin use for a Respiratory Syncytial Virus (RSV) outbreak following Hematopoietic Stem Cell Transplantation (HSCT) in a tertiary care center
Cornfield, B.
Chung, H.
Clark, W.
McCarty, J.
Silveira, F.
Roberts, C.
Toor, A.
De la Cruz, O.
BONE MARROW TRANSPLANTATION, 2016, 51 : S198 - S198
[4] Intravenous ribavirin is safe and effective for respiratory syncytial virus infection after lung transplantation
Glanville, AR
Scott, AIR
Morton, J
Aboyoun, CL
Plit, M
Malouf, MA
IMMUNOLOGY AND CELL BIOLOGY, 2005, 83 (04): : A1 - A1
[5] ROLE OF ORAL RIBAVIRIN IN THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS IN PATIENTS SUBJECTED TO ALLOGENEIC TRANSPLANT
Raposo Puglia, J. A.
Madrigal Toscano, M. D.
Saldana Moreno, R.
Rubio Sanchez, V
Cabeza de Vaca, Verdugo M. V.
Manzanares Perez, M.
Salamanca Cuenca, A.
Palacio Heidy, Campo J.
Garzon Lopez, S.
HAEMATOLOGICA, 2015, 100 : 216 - 217
[6] Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation
Glanville, AR
Scott, AIR
Morton, FM
Aboyoun, CL
Plit, ML
Carter, IW
Malouf, MA
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (12): : 2114 - 2119
[7] Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplant
Glanville, A. R.
Aboyoun, C. L.
Plit, M. L.
Malouf, M. A.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : S77 - S78
[8] RIBAVIRIN (R) FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION - WHEN AND IF SO, HOW
KRILOV, LR
MANDEL, FG
PEDIATRIC RESEARCH, 1991, 29 (04) : A177 - A177
[9] Respiratory syncytial virus infection outbreak and successful treatment with IVIG and oral ribavirin among pediatric patients with oncologic diseases and/or BMT.
Anak, Sema S.
Atay, Didem
Garipardic, Mesut
Ozalp, Berit
Yani, Diana
Agaaoglu, Leyla
Ozturk, Gulyuz
Unuvar, Aysegul
Karakas, Zeynep
Devecioglu, Omer
BLOOD, 2006, 108 (11) : 408B - 409B
[10] Oral and Inhaled Ribavirin Treatment for Respiratory Syncytial Virus Infection in Lung Transplant Recipients
Permpalung, Nitipong
Thaniyavarn, Tany
Saullo, Jennifer L.
Arif, Sana
Miller, Rachel A.
Reynolds, John M.
Alexander, Barbara D.
TRANSPLANTATION, 2020, 104 (06) : 1280 - 1286

← 1 2 3 4 5 →